快速作用抗抑郁药的表观遗传机制
Antonio Inserra1,2, Antonella Campanale3, Tamim Rezai3
1Department of Psychiatry, McGill University, Montreal, QC, Canada. antonio.inserra@mail.mcgill.ca.
Translational psychiatry
|September 4, 2024
概括
快速作用抗抑郁药 (RAADs) 可能会改变表观遗传过程,影响大脑中的基因表达. 需要进一步的研究,以了解这些表观遗传变化的治疗效果的因果作用.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 快速作用抗抑郁药 (RAADs) 通过调节神经可塑性,神经传递和免疫力,为精神疾病提供治疗效益.
- 这些影响可能涉及重塑色素和调节基因表达的表观遗传过程.
研究的目的:
- 审查已知的机制,知识差距和RAADs表观遗传效应的未来方向.
- 为了比较RAADs与传统抗抑郁药的表观遗传效应,重点关注对应激反应的大脑区域.
主要方法:
- 关于RAADs和表观遗传学的现有文献的前景审查.
- 专注于应激反应的DNA和大脑区域的表观遗传调节.
- 与传统抗抑郁药的表观遗传机制进行比较.
主要成果:
- 初步证据表明,RAADs诱导的表观遗传变化 (DNA甲基化,基因质修饰,非编码RNA调节) 与传统抗抑郁药类似.
- 这些变化发生在参与神经营养,神经传递和免疫调节的应激响应大脑区域.
- 因果关系,细胞类型特异性和精确的机制仍未确定.
结论:
- 观察到与RAADs相关的表观遗传变化,但它们在治疗效果中的因果作用尚不清楚.
- 对机制和细胞特异性影响的进一步研究至关重要.
- 了解这些表观遗传途径可能会导致基于神经表观遗传学的新型精密疗法.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
205
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
205
Antidepressant Drugs: Overview
389
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
389
Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
335
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
335
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
Desensitization and Tachyphylaxis
1.6K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.6K


